Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Clinical trial NCT02100969 · COMPLETED
Trial details
- NCT number
- NCT02100969
- Sponsor
- Mazen Dimachkie, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2017-11-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.